UniProtKB AC (Name) | UniProtKB Section | Organism | Description | |
---|---|---|---|---|
Q6BDI9 (REP15_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Rab15 effector protein; | |
Q8IZU3 (SYCP3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Synaptonemal complex protein 3; | |
O95833 (CLIC3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Chloride intracellular channel protein 3; Glutaredoxin-like oxidoreductase CLIC3; | |
Q86WR6 (CHCT1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | CHD1 helical C-terminal domain containing protein 1; | |
Q0VD86 (INCA1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein INCA1; Inhibitor of CDK interacting with cyclin A1; | |
P50553 (ASCL1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Achaete-scute homolog 1; Class A basic helix-loop-helix protein 46; | |
P31260 (HXA10_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Homeobox protein Hox-A10; Homeobox protein Hox-1.8; Homeobox protein Hox-1H; PL; | |
Q9BQ50 (TREX2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Three prime repair exonuclease 2; 3'-5' exonuclease TREX2; | |
Q9UHV2 (SRTD1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | SERTA domain-containing protein 1; CDK4-binding protein p34SEI1; Transcriptional regulator interacting with the PHD-bromodomain 1; | |
P22794 (EVI2A_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein EVI2A; Ecotropic viral integration site 2A protein homolog; | |
Q9H5I1 (SUV92_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Histone-lysine N-methyltransferase SUV39H2; Histone H3-K9 methyltransferase 2; Lysine N-methyltransferase 1B; Suppressor of variegation 3-9 homolog 2; | |
P49427 (UB2R1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Ubiquitin-conjugating enzyme E2 R1; (E3-independent) E2 ubiquitin-conjugating enzyme R1; E2 ubiquitin-conjugating enzyme R1; Ubiquitin-conjugating enzyme E2-32 kDa complementing; Ubiquitin-conjugating enzyme E2-CDC34; Ubiquitin-protein ligase R1; | |
Q9NZA1 (CLIC5_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Chloride intracellular channel protein 5; Glutaredoxin-like oxidoreductase CLIC5; | |
P60033 (CD81_HUMAN) | Swiss-Prot | Homo sapiens (Human) | CD81 antigen; 26 kDa cell surface protein TAPA-1; Target of the antiproliferative antibody 1; Tetraspanin-28; CD81; | |
Q9BV87 (CNPD1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein CNPPD1; Cyclin Pas1/PHO80 domain-containing protein 1; | |
Q2MJR0 (SPRE3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Sprouty-related, EVH1 domain-containing protein 3; | |
Q7KZN9 (COX15_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Heme A synthase COX15; Cytochrome c oxidase assembly protein COX15 homolog; | |
Q9Y4P9 (SPEF1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Sperm flagellar protein 1; | |
P41238 (ABEC1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | C->U-editing enzyme APOBEC-1; Apolipoprotein B mRNA-editing enzyme catalytic subunit 1; HEPR; mRNA(cytosine(6666)) deaminase 1; | |
Q13569 (TDG_HUMAN) | Swiss-Prot | Homo sapiens (Human) | G/T mismatch-specific thymine DNA glycosylase; Thymine-DNA glycosylase; | |
Q9P2E8 (MARH4_HUMAN) | Swiss-Prot | Homo sapiens (Human) | E3 ubiquitin-protein ligase MARCHF4; Membrane-associated RING finger protein 4; Membrane-associated RING-CH protein IV; RING finger protein 174; RING-type E3 ubiquitin transferase MARCHF4; | |
Q5JPI9 (EFMT2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | EEF1A lysine methyltransferase 2; Methyltransferase-like protein 10; Protein-lysine N-methyltransferase METTL10; | |
Q8N6I1 (EID2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | EP300-interacting inhibitor of differentiation 2; CREBBP/EP300 inhibitor 2; EID-1-like inhibitor of differentiation 2; | |
Q9BT25 (HAUS8_HUMAN) | Swiss-Prot | Homo sapiens (Human) | HAUS augmin-like complex subunit 8; HEC1/NDC80-interacting centrosome-associated protein 1; Sarcoma antigen NY-SAR-48; | |
Q14353 (GAMT_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Guanidinoacetate N-methyltransferase; | |
Q86UP9 (LHPL3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | LHFPL tetraspan subfamily member 3 protein; Lipoma HMGIC fusion partner-like 3 protein; | |
Q66K80 (RUAS1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative uncharacterized protein RUSC1-AS1; RUSC1 antisense RNA 1; RUSC1 antisense gene protein 1; | |
Q96EC8 (YIPF6_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein YIPF6; YIP1 family member 6; | |
Q96P09 (BIRC8_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Baculoviral IAP repeat-containing protein 8; Inhibitor of apoptosis-like protein 2; Testis-specific inhibitor of apoptosis; | |
Q8WV74 (NUDT8_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Mitochondrial coenzyme A diphosphatase NUDT8; Nucleoside diphosphate-linked moiety X motif 8; | |
Q96K37 (S35E1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Solute carrier family 35 member E1; | |
P24864 (CCNE1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | G1/S-specific cyclin-E1; | |
Q99574 (NEUS_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Neuroserpin; Peptidase inhibitor 12; Serpin I1; | |
Q9BX46 (RBM24_HUMAN) | Swiss-Prot | Homo sapiens (Human) | RNA-binding protein 24; RNA-binding motif protein 24; RNA-binding region-containing protein 6; | |
Q96PC2 (IP6K3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Inositol hexakisphosphate kinase 3; Inositol hexaphosphate kinase 3; | |
Q96FA7 (ZB10P_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative protein ZBED10P; ZBED6 C-terminal-like protein; zinc finger BED-type containing 10 pseudogene; | |
Q14186 (TFDP1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Transcription factor Dp-1; DRTF1-polypeptide 1; E2F dimerization partner 1; | |
P13473 (LAMP2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Lysosome-associated membrane glycoprotein 2; CD107 antigen-like family member B; LGP-96; CD107b; | |
O75121 (MFA3L_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Microfibrillar-associated protein 3-like; Testis development protein NYD-SP9; | |
Q8N831 (TSYL6_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Testis-specific Y-encoded-like protein 6; | |
P21128 (ENDOU_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Uridylate-specific endoribonuclease; Placental protein 11; Protein endoU; | |
Q96LZ7 (RMD2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Regulator of microtubule dynamics protein 2; Protein FAM82A1; | |
Q6NVV3 (NIPA3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Magnesium transporter NIPA3; NIPA-like protein 1; Non-imprinted in Prader-Willi/Angelman syndrome region protein 3; | |
Q9UNK0 (STX8_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Syntaxin-8; | |
Q9Y679 (AUP1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Lipid droplet-regulating VLDL assembly factor AUP1; Ancient ubiquitous protein 1; | |
Q9Y303 (NAGA_HUMAN) | Swiss-Prot | Homo sapiens (Human) | N-acetylglucosamine-6-phosphate deacetylase; Amidohydrolase domain-containing protein 2; | |
O15482 (TEX28_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Testis-specific protein TEX28; | |
Q8IWB7 (WDFY1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | WD repeat and FYVE domain-containing protein 1; FYVE domain-containing protein localized to endosomes 1; Phosphoinositide-binding protein 1; WD40- and FYVE domain-containing protein 1; Zinc finger FYVE domain-containing protein 17; | |
Q96L33 (RHOV_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Rho-related GTP-binding protein RhoV; CDC42-like GTPase 2; GTP-binding protein-like 2; Rho GTPase-like protein ARHV; Wnt-1 responsive Cdc42 homolog 2; | |
Q6UX27 (VSTM1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | V-set and transmembrane domain-containing protein 1; Signal inhibitory receptor on leukocytes-1; |
Homo sapiens (Latin: "wise man") is the species name for humans. Believed to have originated in Africa, Homo sapiens is the only surviving member of the Homo genus.
The first complete draft of the human genome was completed in 2001 with an estimated cost of $300million. With the advances in DNA sequencing methods, this price has dropped dramatically down to almost $1000 per genome. By combining the individual genome information with other data, such as protein structure models, personalised medicine becomes viable.
From left to right: i) The number of proteins in the reference proteome of Homo sapiens, ii) the number of unique protein sequences for which at least one model is available, iii) the total number of models and iv) a coverage bar plot is shown.
The bar plot shows the coverage for every protein in the reference proteome of Homo sapiens for which there is at least one model. Different colours (dark green to red boxes) represent the coverage of the targets. Targets with high coverage are represented in dark green (more than 80% of the target's length is covered by models), whereas low coverage is shown in red. The size of each box is proportional to the number of target sequences with a given coverage.
For information on the latest proteome for Homo sapiens, please visit Proteome.
You can easily download the latest protein sequences for Homo sapiens proteome here. Please note this download is for the current UniProtKB release, which may be different to release 2025_03 that was used for the most up to date SWISS-MODEL Repository.
Proteins in proteome | Sequences modelled | Models |
20,663 | 17,634 | 43,400 |
Detailed coverage numbers are obtained by hovering the mouse over one of the boxes.
The plot shows the evolution over years (x-axis) of the fraction of Homo sapiens reference proteome residues (y-axis) for which structural information is available. Different colors (light blue to dark blue) in the plot represent the quality of the sequence alignment between the reference proteome sequences (targets) and the sequences of the proteins in the structure database (templates). Alignments with low sequence identity are displayed in light blue, whereas alignments with high sequence identity are depicted in dark blue. The SWISS-MODEL Template Library is used as database of templates. Only target-template alignments found by HHblits and only residues with atom coordinates are considered.
This chart shows the percentage of residues in the Homo sapiens proteome which are covered by experimental structures and the enhancement of coverage by homology modelling by the SWISS-MODEL pipeline. Experimental residue coverage is determined using SIFTS mapping. For residues which are not covered by experimental structures (including where there are no atom records in SIFTS mapping) the model coverage bars are coloured by QMEANDisCo local quality score.
Many proteins form oligomeric structures either by self-assembly (homo-oligomeric) or by assembly with other proteins (hetero-oligomeric) to accomplish their function. In SWISS-MODEL Repository, the quaternary structure annotation of the template is used to model the target sequence in its oligomeric form. Currently our method is limited to the modelling of homo-oligomeric assemblies. The oligomeric state of the template is only considered if the interface is conserved.
Single Chain | 2-mer | 3-mer | 4-mer | 5-mer | 6-mer | 7-mer | 8-mer | 9-mer | 10-mer | 11-mer | 12-mer | 13-mer | 14-mer | 16-mer | 18-mer | 20-mer | 21-mer | 22-mer | 24-mer | 25-mer | 26-mer | 32-mer | 34-mer | 36-mer | 39-mer | 40-mer | 44-mer | 46-mer | 48-mer | 51-mer | 56-mer | 60-mer | 62-mer |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
38,729 | 3,287 | 322 | 617 | 63 | 135 | 20 | 53 | 2 | 24 | 9 | 45 | 1 | 3 | 17 | 11 | 2 | 1 | 1 | 16 | 2 | 1 | 4 | 1 | 2 | 1 | 7 | 1 | 2 | 4 | 2 | 1 | 12 | 2 |